NCT02791386View on ClinicalTrials.gov

Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy

CompletedOBSERVATIONAL
Enrollment

383

Participants

Timeline

Start Date

November 22, 2016

Primary Completion Date

October 30, 2017

Study Completion Date

October 30, 2017

Conditions
Hepatitis B
Trial Locations (1)

410011

Local Institution, Changsha

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT02791386 - Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy | Biotech Hunter | Biotech Hunter